Contributing authors: Kanishka Sharma (Director MR Imaging) and Bettina Selig (Specialist in Image Processing and Software Development) @ Antaros Medical
Artificial Intelligence (AI) is everywhere these days, from predicting which series you’ll watch next to powering self-driving cars. But in medical imaging, AI isn’t exactly new. In fact, its roots go back decades to when early algorithms were used to assist radiologists with the automated detection of clinical abnormalities. What’s changed is the scale, sophistication, and speed at which AI now operates. Today, AI is not just a helpful tool, it’s becoming a game changer, both in diagnostics and clinical trials.
AI in medical imaging: not a new concept
Before diving into the future, let’s acknowledge the past. AI has been quietly working behind the scenes in medical imaging for years. The early systems were deterministic and rigid, meaning they could not discriminate between complex features as they were built on hard, rule-based logic. By the 1990s, the field shifted towards probabilistic machine learning whereby hand-crafted statistical patterns could use confidence levels to better identify features like the edges of a lung nodule or the texture of a breast lesion. From feature extraction to complex pattern recognition, early applications were foundational to enhancing image quality, automating analysis, and standardizing the quantification of clinical data.
The future: AI’s expanding role in medical imaging
What’s new is the explosion of data, computing power, and the recent shift from classic machine learning to sophisticated deep learning algorithms. Today, AI is transforming medical imaging into a precision powerhouse through:
- Automated image analysis: AI can rapidly process thousands of images, thereby mitigating human error and freeing up radiologists’ time to be used instead for complex decision-making.
- Predictive insights: From imaging data to quantitative imaging biomarkers, AI can predict disease progression, guiding clinicians in making proactive treatment decisions.
- Personalized medicine: AI-driven integration of imaging biomarkers with genomic and clinical data can tailor insights to individual patients, supporting precision therapies that are more targeted and effective.
AI in clinical trials: a catalyst for precision and speed, not a replacement for human expertise
Imaging plays a critical role in clinical trials by providing insights and evidence regarding whether a drug works and how. Traditionally, analyzing imaging data in trials has been complex, time-consuming, and prone to variability. AI as a tool is a powerful enabler, but it cannot replace the human input and oversight that make imaging so valuable in clinical trials in the first place.
For example, setting up imaging protocols, deciding what to image, and ensuring the right sequences are captured require deep expertise and clinical judgment. AI doesn’t replace that; it builds on it and acts as a vital bridge for protocol harmonization, facilitating consistency across diverse scanner types and vendors.
Once the images are acquired, AI then takes over the computational burden of processing and interpretation, the ‘heavy lifting’, via:
- Standardization across sites: AI can standardize data from multiple trial sites, reducing variability and ensuring a uniform dataset for consistent analysis.
- Accelerated timelines: Automated, or even semi-automated, image analysis means faster readouts, which can significantly shorten trial durations.
- Biomarker discovery: AI can uncover subtle imaging biomarkers that humans might miss, opening doors to new endpoints and more sensitive measures of drug efficacy and disease progression.
- Data integration: AI doesn’t just look at images, it can integrate imaging with other data sources (for example genomics or clinical data) to create a holistic view of treatment response, enabling better patient stratification.
The result? The combination of human expertise and oversight with AI makes imaging in clinical trials more robust, reproducible, and insightful than ever before.
At Antaros Medical, we don’t use AI for AI’s sake. We use it to strengthen human-led, biology-driven imaging science. Our deep learning enabled quantitative image analysis enhances sensitivity, repeatability, and reproducibility across complex imaging datasets, not by replacing experts, but by empowering them with more precision and consistency.
Why this matters in drug development
For drug developers, this isn’t just about efficiency, it’s about confidence. AI-powered imaging provides robust, reproducible evidence that can make or break regulatory submissions. For patients, it means faster access to life-changing therapies.
Closing thoughts
AI isn’t replacing the need for human involvement in medical imaging; it’s complementing it. By taking on the computational burden of repetitive analysis and ensuring consistency across sites, AI optimizes the time of humans to focus on designing imaging approaches and interpreting the results in context. As a tool in clinical trials, AI strengthens the utility of imaging methods for understanding drug effects, extracting even more detail and offering opportunities for data integration. The evolution of AI in medical imaging is still unfolding, and it’s exciting to think about how it may be used further in the future.
Blog disclaimer
The views and opinions expressed in this article are solely those of the contributing author/s. These views and opinions do not necessarily represent those of Antaros Medical.
Contact details
If you have any questions regarding this article, please reach out to press@antarosmedical.com